Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce To

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Plos One|February 24, 2012
Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparumMarcin Poreba, Sheena McGowan, Tina S Skinner-Adams, et al.
Infectious Disorders Drug Targets|March 26, 2010
Aminopeptidases of malaria parasites: new targets for chemotherapyKatharine R Trenholme, Christopher L Brown, Tina S Skinner-Adams, et al.
Plos Neglected Tropical Diseases|April 13, 2011
Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepaticaMark W Robinson, Ileana Corvo, Peter M Jones, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 9, 2012
A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPaseMark W Robinson, Raquel Alvarado, Joyce To, et al.
Microbiome|November 28, 2025
Prediction of symptomatic and asymptomatic bacteriuria in spinal cord injury patients using machine learningM Mozammel Hoque, Parisa Noorian, Gustavo Espinoza-Vergara, et al.
Microbiology Spectrum|December 30, 2025
Profiling of <i>Burkholderia pseudomallei</i> variants derived from Queensland's clinical isolatesPauline M L Coulon, Kay Ramsay, Aven Lee, et al.
Plos One|December 18, 2025
Co-isolation of genetically distinct Burkholderia pseudomallei strains from a single patient in North QueenslandPauline M L Coulon, Piklu Roy Chowdhury, Ian Gassiep, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2025
An immunoregulatory amphipathic peptide derived from Fasciola hepatica helminth defense molecule (FhHDM-1.C2) exhibits potent biotherapeutic activity in a murine model of multiple sclerosisRichard Lalor, Akane Tanaka, Jenna Shiels, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2018
The parasitic 68-mer peptide FhHDM-1 inhibits mixed granulocytic inflammation and airway hyperreactivity in experimental asthmaAkane Tanaka, Venkata Sita Rama Raju Allam, Jennifer Simpson, et al.
Biofilm|December 23, 2025
A model, mixed-species urinary catheter biofilm derived from spinal cord injury patientsParisa Noorian, Kailey Hamann, M Mozammel Hoque, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Plos One|February 24, 2012
Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparumMarcin Poreba, Sheena McGowan, Tina S Skinner-Adams, et al.
Infectious Disorders Drug Targets|March 26, 2010
Aminopeptidases of malaria parasites: new targets for chemotherapyKatharine R Trenholme, Christopher L Brown, Tina S Skinner-Adams, et al.
Plos Neglected Tropical Diseases|April 13, 2011
Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepaticaMark W Robinson, Ileana Corvo, Peter M Jones, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 9, 2012
A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPaseMark W Robinson, Raquel Alvarado, Joyce To, et al.
Microbiome|November 28, 2025
Prediction of symptomatic and asymptomatic bacteriuria in spinal cord injury patients using machine learningM Mozammel Hoque, Parisa Noorian, Gustavo Espinoza-Vergara, et al.
Microbiology Spectrum|December 30, 2025
Profiling of <i>Burkholderia pseudomallei</i> variants derived from Queensland's clinical isolatesPauline M L Coulon, Kay Ramsay, Aven Lee, et al.
Plos One|December 18, 2025
Co-isolation of genetically distinct Burkholderia pseudomallei strains from a single patient in North QueenslandPauline M L Coulon, Piklu Roy Chowdhury, Ian Gassiep, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2025
An immunoregulatory amphipathic peptide derived from Fasciola hepatica helminth defense molecule (FhHDM-1.C2) exhibits potent biotherapeutic activity in a murine model of multiple sclerosisRichard Lalor, Akane Tanaka, Jenna Shiels, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2018
The parasitic 68-mer peptide FhHDM-1 inhibits mixed granulocytic inflammation and airway hyperreactivity in experimental asthmaAkane Tanaka, Venkata Sita Rama Raju Allam, Jennifer Simpson, et al.
Biofilm|December 23, 2025
A model, mixed-species urinary catheter biofilm derived from spinal cord injury patientsParisa Noorian, Kailey Hamann, M Mozammel Hoque, et al.
Pageof 4